Telitacicept: A New Therapy for the Treatment of Optic Neuromyelitis Spectrum Disease Associated with Other Autoimmune Disorders

Shaomin Zuo,1 Wenning Yang,1 Siyu Zhang,2 Shuyue Sun,2 Songke Lu,2 Chengcheng Lu,1 Wei Li3 1Department of Neurology, People’s Hospital of Henan University, Zhengzhou, People’s Republic of China; 2Department of Neurology, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of Chin...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zuo S, Yang W, Zhang S, Sun S, Lu S, Lu C, Li W
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2025-04-01
Edice:	Biologics: Targets & Therapy
Témata:	neuromyelitis optica spectrum disorders;telitacicept;blys;april
On-line přístup:	https://www.dovepress.com/telitacicept-a-new-therapy-for-the-treatment-of-optic-neuromyelitis-sp-peer-reviewed-fulltext-article-BTT
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!